Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Digital patient experiences are enhanced to connect with individuals during their most crucial moments. By offering tailored solutions that resonate with each patient’s unique needs and providing essential support, the aim is to foster personal engagement that aids patients throughout their treatment journey. It is vital to maintain transparency and guidance during what can be an overwhelming process. Through an integrated platform, digital connectivity ensures real-time support, keeping every patient’s care network aligned throughout their treatment experience. Patients benefit from comprehensive treatment management that combines cutting-edge technology with expert knowledge. Data-driven insights fuel an innovative digital platform that promotes human engagement, ultimately delivering a holistic care experience. Our digital solution addresses a significant need by educating, reminding, and coaching both patients and caregivers at every step of the treatment journey. Additionally, JITI technology takes a proactive approach by intervening with patients to enhance their engagement and support. By prioritizing these elements, we aim to improve overall patient satisfaction and outcomes during challenging times.
Description
Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
Free
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Medisafe
Country
United States
Website
www.medisafe.com/solutions/
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/medication-management/omda-cytodose/
Product Features
Patient Engagement
Appointment Scheduling
Care Planning
Collaboration
Messaging
Mobile Access
Patient Education
Patient Portal
Personal Health Record
Progress Tracking
Self Management